AIM ImmunoTech Inc.(AIM)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-06-16 | Equels Thomas K CEO & President | Purchase | +107 | +0.28%38,885 | $7.70 | $824 | View SEC filing | |
| 2025-06-13 | Equels Thomas K CEO & President | Purchase | +103 | +0.27%38,675 | $8.70 | $896 | View SEC filing | |
| 2025-04-23 | MITCHELL WILLIAM M Director | Purchase | +196,851 | +60.52%522,103 | $0.03 | $5,000 | View SEC filing | |
| 2025-04-23 | Equels Thomas K CEO & President | Purchase | +1,968,504 | +103.66%3,867,533 | $0.03 | $50,000 | View SEC filing | |
| 2025-04-23 | KELLNER TED D Director | Purchase | +1,968,504 | +112.36%3,720,504 | $0.03 | $50,000 | View SEC filing | |
| 2025-04-07 | Equels Thomas K CEO & President | Purchase | +41,000 | +2.21%1,899,029 | $0.06 | $2,583 | View SEC filing | |
| 2025-04-04 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +500 | +0.12%401,762 | $0.09 | $44 | View SEC filing | |
| 2025-03-06 | Equels Thomas K CEO & President | Purchase | +50,000 | +2.77%1,858,029 | $0.13 | $6,730 | View SEC filing | |
| 2025-03-05 | Equels Thomas K CEO & President | Purchase | +44,000 | +2.49%1,808,029 | $0.12 | $5,060 | View SEC filing | |
| 2025-03-04 | Equels Thomas K CEO & President | Purchase | +83,334 | +4.96%1,764,029 | $0.12 | $10,000 | View SEC filing | |
| 2025-01-21 | Equels Thomas K CEO & President | Purchase | +20,000 | +1.22%1,657,968 | $0.21 | $4,240 | View SEC filing | |
| 2024-12-20 | MITCHELL WILLIAM M Director | Sale | -4,580 | -3.71%118,929 | $0.19 | $884 | View SEC filing | |
| 2024-12-19 | Equels Thomas K CEO & President | Purchase | +22,727 | +1.37%1,680,695 | $0.21 | $4,682 | View SEC filing | |
| 2024-12-04 | APPELROUTH STEWART Director | Purchase | +11,112 | +3.23%355,509 | $0.21 | $2,356 | View SEC filing | |
| 2024-11-21 | Equels Thomas K CEO & President | Purchase | +85,000 | +5.47%1,637,968 | $0.20 | $16,915 | View SEC filing | |
| 2024-11-21 | APPELROUTH STEWART Director | Purchase | +81,953 | +34.18%321,752 | $0.19 | $15,817 | View SEC filing | |
| 2024-11-20 | Equels Thomas K CEO & President | Purchase | +60,110 | +4.03%1,552,968 | $0.18 | $11,000 | View SEC filing | |
| 2024-09-17 | Equels Thomas K CEO & President | Purchase | +5,000 | +0.34%1,493,042 | $0.30 | $1,515 | View SEC filing | |
| 2024-09-16 | Equels Thomas K CEO & President | Purchase | +20,000 | +1.36%1,488,042 | $0.31 | $6,160 | View SEC filing | |
| 2024-05-07 | Equels Thomas K CEO & President | Purchase | +61,729 | +8.62%778,184 | $0.40 | $25,000 | View SEC filing | |
| 2024-05-07 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +30,865 | +16.99%212,583 | $0.41 | $12,500 | View SEC filing | |
| 2024-03-22 | BRYAN NANCY Director | Purchase | +38,462 | +100.00%38,462 | $0.39 | $15,000 | View SEC filing | |
| 2024-03-18 | Rodino Peter W III COO, Secretary, Gen. Counsel | Purchase | +37,879 | +26.33%181,718 | $0.33 | $12,500 | View SEC filing | |
| 2024-03-18 | Equels Thomas K CEO & President | Purchase | +75,758 | +11.82%716,455 | $0.33 | $25,000 | View SEC filing | |
| 2024-03-18 | APPELROUTH STEWART Director | Purchase | +90,910 | +61.07%239,765 | $0.33 | $30,000 | View SEC filing |
1-25 of 127